查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1446913

營養基因組學市場：按產品類型、應用和最終用戶分類：2023-2032 年全球機會分析和產業預測

Nutrigenomics Market By Product Type, By Applications, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3個工作天內

價格

營養基因組學是對特定基因突變或多態性存在的研究，在大多數情況下，這僅意味著對特定疾病過程的易感性，而環境和行為因素的複雜性，例如個體化的營養攝入，可能可以預防這種情況。

營養基因體學是研究特定營養素和營養補充食品個體基因組成表現的影響。

營養基因組學市場-IMG1

肥胖、糖尿病和心血管疾病等慢性病盛行率的上升正在推動營養基因組學測試市場的成長。在過去的十年中，蛋白質組學、基因組學和代謝體學等組學技術迅速發展，並與先進的生物資訊學相結合，已廣泛用於基於蛋白質途徑的疾病識別。目前，營養基因組學研究結果在一定程度上被用於治療與飲食因素有關的疾病，如糖尿病、癌症、肥胖等，顯著擴大了營養基因組學檢測市場規模。

營養基因組學測試結果的準確性和可靠性是許多消費者最關心的問題之一。直接面對消費者的測試，包括營養基因組學測試，有不同程度的證據來支持他們的主張。一些直接面對消費者的測試有更多的科學和臨床資料來支持它們提供的資訊，而其他測試則有更少的資料來支持它們。此外，臨床界對於各種基因突變在導致疾病中所扮演的角色存在分歧，這也影響了測試的準確性和可靠性。此外，並非所有變異都會導致個體患有某種疾病或病症的風險，因此陰性結果並不能減輕個體患有特定疾病或病症的風險，客戶必須了解這一點。對於同一疾病，相同的營養基因組學測試可能會給出不同的結果，因為不同的公司測試不同的變異。因此，客戶在訂購營養基因組學測試和解釋結果時應自行判斷。因此，營養基因組學測試結果不被認為準確可靠，進一步阻礙了整體需求。

運動營養基因體學是營養基因體學測試市場的另一個重要機會。因此，運動員尋求量身定做的飲食來改善他們的健康。運動員群體的個人化營養旨在透過針對個人遺傳特徵的飲食建議來最佳化健康、身體組成和運動表現。運動營養師和註冊營養師長期以來擅長在一般飲食指南中添加付加的分析，以適應不同的運動人群。然而，一般的「一刀切」建議仍然存在。眾所周知，遺傳差異會影響營養物質和食品生物活性物質的吸收、代謝、攝取、利用和排泄，最終影響許多代謝途徑。營養基因組學和營養遺傳學是利用基因組資訊和基因測試技術來檢查個體遺傳差異在改變運動員對營養素和其他食品成分的反應中所起的作用的實驗方法。儘管很少有隨機對照試驗來檢驗遺傳變異對強效補充食品的影響，但有證據表明基因-飲食交互作用對影響運動和運動表現的營養狀況生物標記的影響。 。這項基礎構成了運動營養基因體學領域持續發展的基礎。

COVID-19 大流行對營養基因組學測試市場的成長產生了重大影響。這次疫情為遠端醫療引入了許多新用戶，進一步增強了其相對於潛在競爭對手的優勢。 COVID-19 大流行也推動了營養基因組學市場內進一步的產業整合和合作。此外，COVID-19 大流行以及由此產生的消費者行為和期望的變化促使各種傳統遠端醫療選項，我也被迫追求它。此外，COVID-19 大流行對遠端醫療的認知、接受和利用產生了積極影響，提高了消費者對虛擬護理的接受度。因此，大流行導致遠距遠端醫療服務的使用增加，預計這將推動大流行後時期的營養基因組市場。

從事銀行網路安全市場的公司包括 Ancestry、Nutrigenomix、23andMe Inc.、DNAfit、GX Sciences Inc.、Xcode Life、Koninklijke DSM NV (Royal DSM)、 BASF SE、Danone SA、The Gene Box 等。

相關人員的主要利益

  • 本報告定量分析了 2022 年至 2032 年營養基因組學市場分析的細分市場、當前趨勢、估計趨勢和動態，並確定了一般營養基因組學市場機會。
  • 我們提供市場研究以及與市場促進因素、市場限制和市場機會相關的資訊。
  • 波特的五力分析揭示了買家和供應商的潛力，幫助相關人員做出利潤驅動的業務決策並加強供應商和買家網路。
  • 營養基因組市場區隔的詳細分析有助於確定市場機會。
  • 每個地區的主要國家都根據其對全球市場的收益貢獻繪製了地圖。
  • 市場參與者定位有助於基準化分析，並提供對市場參與者當前位置的清晰了解。
  • 它包括區域和全球營養基因組學市場趨勢、主要企業、細分市場、應用領域、市場成長策略等的分析。

可以使用此報告進行客製化

  • 消費者購買行為分析
  • 最終用戶偏好和痛點
  • 投資機會
  • 按地區分類的新參與企業
  • 科技趨勢分析
  • 打入市場策略
  • 按產品/細分市場區隔
  • 痛點分析
  • 監管指引
  • 策略建議
  • 針對客戶興趣的其他公司簡介
  • 按國家或地區進行的附加分析 – 市場規模和預測
  • 十字交叉細分市場分析 - 市場規模與預測
  • 公司簡介的擴充列表
  • 歷史市場資料
  • 全球/區域/國家層級參與者的市場佔有率分析
  • SWOT分析

目錄

第1章簡介

第 2 章執行摘要

第3章市場概況

  • 市場定義和範圍
  • 主要發現
    • 影響因素
    • 主要投資機會
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
  • 市場佔有率分析
  • 品牌佔有率分析
  • 價值鏈分析
  • 監管指引
  • 關鍵監管分析

第4章營養基因體學市場：依產品類型

  • 概述
  • 試劑和套件
  • 服務

第5章營養基因體學市場，依應用

  • 概述
  • 肥胖
  • 糖尿病
  • 心血管疾病
  • 癌症研究

第6章營養基因組學市場：依最終用戶分類

  • 概述
  • 網路平台
  • 醫院和診所
  • 其他

第7章營養基因體學市場：按地區

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 其他
  • 拉丁美洲/中東/非洲
    • 巴西
    • UAE
    • 沙烏地阿拉伯
    • 南非
    • 其他

第8章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 2022年主要企業定位

第9章 公司簡介

  • Cura Integrative Medicine
  • Holistic Health
  • Metagenics, Inc.
  • GX Sciences Inc.
  • The Gene Box
  • Nutrigenomix Inc.
  • Xcode Life
  • DNA Life
  • Interleukin Genetics
  • Genova Diagnostics
Product Code: A129082

Nutrigenetics studies the presence of a particular gene variant or polymorphism that in most cases merely connotes a predisposition to a particular disease process that may be prevented through a complex interplay of environmental and behavioral factors such as a personalized nutrition. Nutrigenomics refers to the study of the effects of specific nutrients or nutraceuticals on the expression of an individual's genetic makeup.

Nutrigenomics Market - IMG1

Rising prevalence of chronic diseases such as obesity, diabetes, and cardiovascular diseases is driving the growth of the nutrigenomics testing market. Over the past decade, rapid advancements in omic technologies such as proteomics, genomics, and metabolomics are combining with advanced bioinformatics to be broadly used for identifying diseases based on protein pathways. Currently, the findings of nutrigenomics have been used to some extent to treat diseases with a diet component like diabetes, cancer, and obesity, significantly boosting the nutrigenomics testing market size.

Accuracy and reliability of the nutrigenomic test findings is one of the major concerns for most of the consumers. Direct-to-consumer tests including nutrigenomic tests have varying levels of evidence that support their claims. Some direct-to-consumer tests have more scientific and clinical data to support the information provided in the test, while other tests do not have as much supporting data. Furthermore, disagreements in the clinical community about the role that different genetic variants are contributing to the disease is another reason affecting the accuracy and reliability of the test. Moreover, not all variants contribute to an individual's risk of getting a disease or condition, so it is important that customers understand that a negative result does not mean that the individual is free from the risk of developing a particular disease or condition. As different companies test for the different set of variants, therefore the same nutrigenomics tests might provide different results for the same disease. Thus, customers need to use their own judgment while ordering and interpreting the results from nutrigenomic tests. Therefore, nutrigenomics test results are not considered as accurate and reliable, further hampering the overall demand.

Sport nutrigenomics is another significant opportunity for nutrigenomics testing market. Thus, athletes are looking for tailor-made diets for improving their health status. Personalized nutrition in athletic populations aims in optimizing health, body composition, and exercise performance by targeting dietary recommendations to an individual's genetic profile. Sport dietitians and nutritionists have long been skilled at placing additional analysis on the one-size-fits-all general population dietary guidelines to accommodate various sporting populations. However, generic 'one-size-fits-all' recommendations still remain. Genetic differences are known to impact absorption, metabolism, uptake, utilization, and excretion of nutrients and food bio actives, which ultimately affects a number of metabolic pathways. Nutrigenomics and nutrigenetics are experimental approaches that use genomic information and genetic testing technologies to examine the role of individual genetic differences in modifying an athlete's response to nutrients and other food components. Although there have been few randomized, controlled trials examining the effects of genetic variation on performance in response to an ergogenic aid, there is a growing foundation of research linking gene-diet interactions on biomarkers of nutritional status, which impact exercise and sport performance. This foundation forms the basis from which the field of sport nutrigenomics continues to develop.

The COVID-19 pandemic had significant impacts on the nutrigenomics testing market growth. The pandemic introduced many new users to telehealth and further reinforced its benefits to potential competitors. In turn, the COVID-19 pandemic has also driven additional industry consolidation or collaboration within the nutrigenomics market. Furthermore, the COVID-19 pandemic, and its resulting changes in consumer behavior and expectations, has also caused various traditional healthcare providers to evaluate and pursue telehealth options that can be paired with their in-person capabilities. Also, telehealth awareness, acceptance, and usage have been positively impacted by the COVID-19 pandemic, leading to increased consumer acceptance of virtual care. Thus, the pandemic led to an increase in the utilization of telehealth services, which is anticipated to boost the nutrigenomics market in the post-pandemic period.

Some of the companies operating in the cybersecurity in banking market are Ancestry, Nutrigenomix, 23andMe Inc., DNAfit, GX Sciences Inc., Xcode Life, Koninklijke DSM N.V. (Royal DSM), BASF SE, Danone S.A., and The Gene Box.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the nutrigenomics market analysis from 2022 to 2032 to identify the prevailing nutrigenomics market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the nutrigenomics market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global nutrigenomics market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Consumer Buying Behavior Analysis
  • End user preferences and pain points
  • Investment Opportunities
  • Upcoming/New Entrant by Regions
  • Technology Trend Analysis
  • Go To Market Strategy
  • Market share analysis of players by products/segments
  • Pain Point Analysis
  • Regulatory Guidelines
  • Strategic Recommedations
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Criss-cross segment analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Market share analysis of players at global/region/country level
  • SWOT Analysis

Key Market Segments

By Product Type

  • Reagents and Kits
  • Services

By Applications

  • Diabetes
  • Cardiovascular Diseases
  • Cancer Research
  • Obesity

By End User

  • Online Platforms
  • Hospitals and Clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Cura Integrative Medicine
    • Holistic Health
    • Metagenics, Inc.
    • GX Sciences Inc.
    • The Gene Box
    • Nutrigenomix Inc.
    • Xcode Life
    • DNA Life
    • Interleukin Genetics
    • Genova Diagnostics

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
  • 3.4. Market dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities
  • 3.5. Market Share Analysis
  • 3.6. Brand Share Analysis
  • 3.7. Value Chain Analysis
  • 3.8. Regulatory Guidelines
  • 3.9. Key Regulation Analysis

CHAPTER 4: NUTRIGENOMICS MARKET, BY PRODUCT TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Reagents and Kits
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Services
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: NUTRIGENOMICS MARKET, BY APPLICATIONS

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Obesity
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Diabetes
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Cardiovascular Diseases
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Cancer Research
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country

CHAPTER 6: NUTRIGENOMICS MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Online Platforms
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Hospitals and Clinics
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: NUTRIGENOMICS MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Product Type
    • 7.2.3. Market size and forecast, by Applications
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Product Type
      • 7.2.5.1.2. Market size and forecast, by Applications
      • 7.2.5.1.3. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Product Type
      • 7.2.5.2.2. Market size and forecast, by Applications
      • 7.2.5.2.3. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Product Type
      • 7.2.5.3.2. Market size and forecast, by Applications
      • 7.2.5.3.3. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Product Type
    • 7.3.3. Market size and forecast, by Applications
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Market size and forecast, by Product Type
      • 7.3.5.1.2. Market size and forecast, by Applications
      • 7.3.5.1.3. Market size and forecast, by End User
      • 7.3.5.2. UK
      • 7.3.5.2.1. Market size and forecast, by Product Type
      • 7.3.5.2.2. Market size and forecast, by Applications
      • 7.3.5.2.3. Market size and forecast, by End User
      • 7.3.5.3. France
      • 7.3.5.3.1. Market size and forecast, by Product Type
      • 7.3.5.3.2. Market size and forecast, by Applications
      • 7.3.5.3.3. Market size and forecast, by End User
      • 7.3.5.4. Spain
      • 7.3.5.4.1. Market size and forecast, by Product Type
      • 7.3.5.4.2. Market size and forecast, by Applications
      • 7.3.5.4.3. Market size and forecast, by End User
      • 7.3.5.5. Italy
      • 7.3.5.5.1. Market size and forecast, by Product Type
      • 7.3.5.5.2. Market size and forecast, by Applications
      • 7.3.5.5.3. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Market size and forecast, by Product Type
      • 7.3.5.6.2. Market size and forecast, by Applications
      • 7.3.5.6.3. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Product Type
    • 7.4.3. Market size and forecast, by Applications
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. China
      • 7.4.5.1.1. Market size and forecast, by Product Type
      • 7.4.5.1.2. Market size and forecast, by Applications
      • 7.4.5.1.3. Market size and forecast, by End User
      • 7.4.5.2. Japan
      • 7.4.5.2.1. Market size and forecast, by Product Type
      • 7.4.5.2.2. Market size and forecast, by Applications
      • 7.4.5.2.3. Market size and forecast, by End User
      • 7.4.5.3. India
      • 7.4.5.3.1. Market size and forecast, by Product Type
      • 7.4.5.3.2. Market size and forecast, by Applications
      • 7.4.5.3.3. Market size and forecast, by End User
      • 7.4.5.4. South Korea
      • 7.4.5.4.1. Market size and forecast, by Product Type
      • 7.4.5.4.2. Market size and forecast, by Applications
      • 7.4.5.4.3. Market size and forecast, by End User
      • 7.4.5.5. Australia
      • 7.4.5.5.1. Market size and forecast, by Product Type
      • 7.4.5.5.2. Market size and forecast, by Applications
      • 7.4.5.5.3. Market size and forecast, by End User
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Market size and forecast, by Product Type
      • 7.4.5.6.2. Market size and forecast, by Applications
      • 7.4.5.6.3. Market size and forecast, by End User
  • 7.5. LAMEA
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Product Type
    • 7.5.3. Market size and forecast, by Applications
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Market size and forecast, by Product Type
      • 7.5.5.1.2. Market size and forecast, by Applications
      • 7.5.5.1.3. Market size and forecast, by End User
      • 7.5.5.2. UAE
      • 7.5.5.2.1. Market size and forecast, by Product Type
      • 7.5.5.2.2. Market size and forecast, by Applications
      • 7.5.5.2.3. Market size and forecast, by End User
      • 7.5.5.3. Saudi Arabia
      • 7.5.5.3.1. Market size and forecast, by Product Type
      • 7.5.5.3.2. Market size and forecast, by Applications
      • 7.5.5.3.3. Market size and forecast, by End User
      • 7.5.5.4. South Africa
      • 7.5.5.4.1. Market size and forecast, by Product Type
      • 7.5.5.4.2. Market size and forecast, by Applications
      • 7.5.5.4.3. Market size and forecast, by End User
      • 7.5.5.5. Rest of LAMEA
      • 7.5.5.5.1. Market size and forecast, by Product Type
      • 7.5.5.5.2. Market size and forecast, by Applications
      • 7.5.5.5.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product mapping of top 10 player
  • 8.4. Competitive dashboard
  • 8.5. Competitive heatmap
  • 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

  • 9.1. Cura Integrative Medicine
    • 9.1.1. Company overview
    • 9.1.2. Key executives
    • 9.1.3. Company snapshot
  • 9.2. Holistic Health
    • 9.2.1. Company overview
    • 9.2.2. Key executives
    • 9.2.3. Company snapshot
  • 9.3. Metagenics, Inc.
    • 9.3.1. Company overview
    • 9.3.2. Key executives
    • 9.3.3. Company snapshot
  • 9.4. GX Sciences Inc.
    • 9.4.1. Company overview
    • 9.4.2. Key executives
    • 9.4.3. Company snapshot
  • 9.5. The Gene Box
    • 9.5.1. Company overview
    • 9.5.2. Key executives
    • 9.5.3. Company snapshot
  • 9.6. Nutrigenomix Inc.
    • 9.6.1. Company overview
    • 9.6.2. Key executives
    • 9.6.3. Company snapshot
  • 9.7. Xcode Life
    • 9.7.1. Company overview
    • 9.7.2. Key executives
    • 9.7.3. Company snapshot
  • 9.8. DNA Life
    • 9.8.1. Company overview
    • 9.8.2. Key executives
    • 9.8.3. Company snapshot
  • 9.9. Interleukin Genetics
    • 9.9.1. Company overview
    • 9.9.2. Key executives
    • 9.9.3. Company snapshot
  • 9.10. Genova Diagnostics
    • 9.10.1. Company overview
    • 9.10.2. Key executives
    • 9.10.3. Company snapshot

LIST OF TABLES

  • TABLE 01. GLOBAL NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 02. NUTRIGENOMICS MARKET FOR REAGENTS AND KITS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. NUTRIGENOMICS MARKET FOR SERVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. GLOBAL NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 05. NUTRIGENOMICS MARKET FOR OBESITY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 06. NUTRIGENOMICS MARKET FOR DIABETES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. NUTRIGENOMICS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. NUTRIGENOMICS MARKET FOR CANCER RESEARCH, BY REGION, 2022-2032 ($MILLION)
  • TABLE 09. GLOBAL NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 10. NUTRIGENOMICS MARKET FOR ONLINE PLATFORMS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. NUTRIGENOMICS MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. NUTRIGENOMICS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. NUTRIGENOMICS MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. NORTH AMERICA NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 15. NORTH AMERICA NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 16. NORTH AMERICA NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 17. NORTH AMERICA NUTRIGENOMICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 18. U.S. NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 19. U.S. NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 20. U.S. NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 21. CANADA NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 22. CANADA NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 23. CANADA NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 24. MEXICO NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 25. MEXICO NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 26. MEXICO NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 27. EUROPE NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 28. EUROPE NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 29. EUROPE NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 30. EUROPE NUTRIGENOMICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 31. GERMANY NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 32. GERMANY NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 33. GERMANY NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 34. UK NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 35. UK NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 36. UK NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 37. FRANCE NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 38. FRANCE NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 39. FRANCE NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 40. SPAIN NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 41. SPAIN NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 42. SPAIN NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 43. ITALY NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 44. ITALY NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 45. ITALY NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 46. REST OF EUROPE NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 47. REST OF EUROPE NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 48. REST OF EUROPE NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 49. ASIA-PACIFIC NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 50. ASIA-PACIFIC NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 51. ASIA-PACIFIC NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 52. ASIA-PACIFIC NUTRIGENOMICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 53. CHINA NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 54. CHINA NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 55. CHINA NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 56. JAPAN NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 57. JAPAN NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 58. JAPAN NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 59. INDIA NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 60. INDIA NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 61. INDIA NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 62. SOUTH KOREA NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 63. SOUTH KOREA NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 64. SOUTH KOREA NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 65. AUSTRALIA NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 66. AUSTRALIA NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 67. AUSTRALIA NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 68. REST OF ASIA-PACIFIC NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 69. REST OF ASIA-PACIFIC NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 70. REST OF ASIA-PACIFIC NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 71. LAMEA NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 72. LAMEA NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 73. LAMEA NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 74. LAMEA NUTRIGENOMICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 75. BRAZIL NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 76. BRAZIL NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 77. BRAZIL NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 78. UAE NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 79. UAE NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 80. UAE NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 81. SAUDI ARABIA NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 82. SAUDI ARABIA NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 83. SAUDI ARABIA NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 84. SOUTH AFRICA NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 85. SOUTH AFRICA NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 86. SOUTH AFRICA NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 87. REST OF LAMEA NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 88. REST OF LAMEA NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022-2032 ($MILLION)
  • TABLE 89. REST OF LAMEA NUTRIGENOMICS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 90. CURA INTEGRATIVE MEDICINE: KEY EXECUTIVES
  • TABLE 91. CURA INTEGRATIVE MEDICINE: COMPANY SNAPSHOT
  • TABLE 92. HOLISTIC HEALTH: KEY EXECUTIVES
  • TABLE 93. HOLISTIC HEALTH: COMPANY SNAPSHOT
  • TABLE 94. METAGENICS, INC.: KEY EXECUTIVES
  • TABLE 95. METAGENICS, INC.: COMPANY SNAPSHOT
  • TABLE 96. GX SCIENCES INC.: KEY EXECUTIVES
  • TABLE 97. GX SCIENCES INC.: COMPANY SNAPSHOT
  • TABLE 98. THE GENE BOX: KEY EXECUTIVES
  • TABLE 99. THE GENE BOX: COMPANY SNAPSHOT
  • TABLE 100. NUTRIGENOMIX INC.: KEY EXECUTIVES
  • TABLE 101. NUTRIGENOMIX INC.: COMPANY SNAPSHOT
  • TABLE 102. XCODE LIFE: KEY EXECUTIVES
  • TABLE 103. XCODE LIFE: COMPANY SNAPSHOT
  • TABLE 104. DNA LIFE: KEY EXECUTIVES
  • TABLE 105. DNA LIFE: COMPANY SNAPSHOT
  • TABLE 106. INTERLEUKIN GENETICS: KEY EXECUTIVES
  • TABLE 107. INTERLEUKIN GENETICS: COMPANY SNAPSHOT
  • TABLE 108. GENOVA DIAGNOSTICS: KEY EXECUTIVES
  • TABLE 109. GENOVA DIAGNOSTICS: COMPANY SNAPSHOT

LIST OF FIGURES

  • FIGURE 01. NUTRIGENOMICS MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF NUTRIGENOMICS MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN NUTRIGENOMICS MARKET
  • FIGURE 04. TOP INVESTMENT POCKETS IN NUTRIGENOMICS MARKET (2023-2032)
  • FIGURE 05. BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. BARGAINING POWER OF BUYERS
  • FIGURE 07. THREAT OF SUBSTITUTION
  • FIGURE 08. THREAT OF SUBSTITUTION
  • FIGURE 09. COMPETITIVE RIVALRY
  • FIGURE 10. GLOBAL NUTRIGENOMICS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. REGULATORY GUIDELINES: NUTRIGENOMICS MARKET
  • FIGURE 12. IMPACT OF KEY REGULATION: NUTRIGENOMICS MARKET
  • FIGURE 13. NUTRIGENOMICS MARKET, BY PRODUCT TYPE, 2022 AND 2032(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF NUTRIGENOMICS MARKET FOR REAGENTS AND KITS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF NUTRIGENOMICS MARKET FOR SERVICES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. NUTRIGENOMICS MARKET, BY APPLICATIONS, 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF NUTRIGENOMICS MARKET FOR OBESITY, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF NUTRIGENOMICS MARKET FOR DIABETES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF NUTRIGENOMICS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF NUTRIGENOMICS MARKET FOR CANCER RESEARCH, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. NUTRIGENOMICS MARKET, BY END USER, 2022 AND 2032(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF NUTRIGENOMICS MARKET FOR ONLINE PLATFORMS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF NUTRIGENOMICS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF NUTRIGENOMICS MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 25. NUTRIGENOMICS MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 26. U.S. NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. CANADA NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. MEXICO NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. GERMANY NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. UK NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. FRANCE NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. SPAIN NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. ITALY NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. REST OF EUROPE NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. CHINA NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. JAPAN NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. INDIA NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. SOUTH KOREA NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. AUSTRALIA NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. REST OF ASIA-PACIFIC NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. BRAZIL NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. UAE NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. SAUDI ARABIA NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 44. SOUTH AFRICA NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 45. REST OF LAMEA NUTRIGENOMICS MARKET, 2022-2032 ($MILLION)
  • FIGURE 46. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 47. COMPETITIVE DASHBOARD
  • FIGURE 48. COMPETITIVE HEATMAP: NUTRIGENOMICS MARKET
  • FIGURE 49. TOP PLAYER POSITIONING, 2022